Drug General Information
Drug ID
D0VT1S
Former ID
DCL000253
Drug Name
TTP889
Drug Type
Small molecular drug
Indication Blood forming organ disorders [ICD10:D75.9] Phase 2 [536572]
Company
TransTech Pharma
Structure
Download
2D MOL

3D MOL

Formula
C25H22N10O3
Canonical SMILES
CC1=NN=NN1NC=C2C=CC(=O)C(=C2)C(C3=CC=C(C=C3)O)C4=CC(=CN<br />N5C(=NN=N5)C)C=CC4=O
InChI
1S/C25H22N10O3/c1-15-28-30-32-34(15)26-13-17-3-9-23(37)21(11-17)25(19-5-7-20(36)8-6-19)22-12-18(4-10-24(22)38)14-27-35-16(2)29-31-33-35/h3-14,25-27,36H,1-2H3/b17-13+,18-14+
InChIKey
PBLRUGKPXXSWKC-HBKJEHTGSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Coagulation factor IX Target Info Inhibitor [536262], [536572]
KEGG Pathway Complement and coagulation cascades
PANTHER Pathway Blood coagulation
PathWhiz Pathway Coagulation
Reactome Extrinsic Pathway of Fibrin Clot Formation
Intrinsic Pathway of Fibrin Clot Formation
Gamma-carboxylation of protein precursors
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
Removal of aminoterminal propeptides from gamma-carboxylated proteins
WikiPathways Complement and Coagulation Cascades
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation
Blood Clotting Cascade
Formation of Fibrin Clot (Clotting Cascade)
References
Ref 536572Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study. J Thromb Haemost. 2008 Mar;6(3):457-63. Epub 2007 Dec 12.
Ref 536262Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery. Drugs. 2006;66(11):1411-29.
Ref 536572Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study. J Thromb Haemost. 2008 Mar;6(3):457-63. Epub 2007 Dec 12.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.